Gordon Gary B., a director at TriSalus Life Sciences, Inc. ($TLSI), made one open market purchase of shares in the last year, totaling $40,000. His most recent buy occurred on February 23, 2026. This ranks him 3,234th out of nearly 5,000 insiders by purchase value, well below the average of $1.46 million across about 3.3 transactions. Gordon Gary B. reported no open market sales of TLSI shares.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2026 | TriSalus Life Sciences, Inc. | $TLSI | Gordon Gary B. | Director | P | Common Stock | 9756 | $4.10 | 9,756.0000 | 49,964,311 | 9999.99% | 0.02% |
| June 12, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Gordon Gary B. | Director | A | Director Stock Option (right to buy) | 15000 | $0.00 | 56,250.0000 | 32,272,462 | 36.36% | 0.05% |
| Jan. 29, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Gordon Gary B. | Not found | A | Director Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 29, 2025 | TriSalus Life Sciences, Inc. | $TLSI | Gordon Gary B. | Not found | A | Director Stock Option (right to buy) | 6250 | $0.00 | 6,250.0000 | 0 | 9999.99% | 0.00% |